{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,8]],"date-time":"2026-03-08T03:01:02Z","timestamp":1772938862172,"version":"3.50.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T00:00:00Z","timestamp":1762128000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T00:00:00Z","timestamp":1762128000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ir J Med Sci"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1007\/s11845-025-04146-5","type":"journal-article","created":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T06:28:25Z","timestamp":1762151305000},"page":"243-254","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Efficacy of intradermal plus intramuscular Recombinant hepatitis B vaccination in vaccine nonresponders"],"prefix":"10.1007","volume":"195","author":[{"given":"Fehmi","family":"Tabak","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3928-3840","authenticated-orcid":false,"given":"Meryem","family":"Sahin Ozdemir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,3]]},"reference":[{"key":"4146_CR1","unstructured":"-Hepatitis B, World Health Organization (WHO). https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/hepatitis-b. Accessed: 07 Nov 2024"},{"issue":"Suppl 1","key":"4146_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.36519\/kd.2023.4673","volume":"36","author":"N Demirt\u00fcrk","year":"2023","unstructured":"Demirt\u00fcrk N, K\u00f6se A, Ural O et al (2023) [Management of chronic hepatitis B infection: A consensus report of the study group for viral hepatitis of the Turkish society of clinical microbiology and infectious Diseases-2023 Update]. Klimik Derg 36(Suppl 1):1\u201322 Turkish","journal-title":"Klimik Derg"},{"issue":"2","key":"4146_CR3","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1046\/j.1365-2893.2003.00487.x","volume":"11","author":"D Lavanchy","year":"2004","unstructured":"Lavanchy D (2004) Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. J Viral Hepat 11(2):97\u2013107","journal-title":"J Viral Hepat"},{"issue":"1","key":"4146_CR4","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1002\/hep.28156","volume":"63","author":"NA Terrault","year":"2016","unstructured":"Terrault NA, Bzowej NH, Chang KM et al (2016) AASLD guidelines for treatment of chronic hepatitis B. Hepatology 63(1):261\u2013283. https:\/\/doi.org\/10.1002\/hep.28156","journal-title":"Hepatology"},{"key":"4146_CR5","doi-asserted-by":"publisher","first-page":"73","DOI":"10.5005\/jp-journals-10018-1264","volume":"8","author":"H \u00d6zkan","year":"2018","unstructured":"\u00d6zkan H (2018) Epidemiology of chronic hepatitis B in Turkey. Euroasian J Hepato-Gastroenterol 8:73\u201374. https:\/\/doi.org\/10.5005\/jp-journals-10018-1264","journal-title":"Euroasian J Hepato-Gastroenterol"},{"issue":"30","key":"4146_CR6","doi-asserted-by":"publisher","first-page":"10383","DOI":"10.3748\/wjg.v20.i30.10383","volume":"20","author":"M Filippelli","year":"2014","unstructured":"Filippelli M, Lionetti E, Gennaro A et al (2014) Hepatitis B vaccine by intradermal route in Non responder patients: an update. World J Gastroenterol 20(30):10383\u201310394. https:\/\/doi.org\/10.3748\/wjg.v20.i30.10383","journal-title":"World J Gastroenterol"},{"issue":"17","key":"4146_CR7","doi-asserted-by":"publisher","first-page":"2044","DOI":"10.1016\/j.vaccine.2015.11.071","volume":"34","author":"W Chonwattana","year":"2016","unstructured":"Chonwattana W, Raengsakulrach B, Holtz TH et al (2016) Hepatitis B vaccination uptake and correlates of serologic response among HIV-infected and uninfected men who have sex with men (MSM) in Bangkok, Thailand. Vaccine 34(17):2044\u20132050. https:\/\/doi.org\/10.1016\/j.vaccine.2015.11.071","journal-title":"Vaccine"},{"key":"4146_CR8","doi-asserted-by":"crossref","unstructured":"CDC (2018) Prevention of hepatitis B virus infection in the united states: recommendations of the advisory committee on immunization practices. MMWR Recomm Rep ;67(No. RR-1).","DOI":"10.15585\/mmwr.rr6701a1"},{"key":"4146_CR9","unstructured":"Non-responders to hepatitis B vaccine are recommended to receive further doses and serological testing. Australian Immunisation Handbook. https:\/\/immunisationhandbook.health.gov.au\/recommendations\/non-responders-to-hepatitis-b-vaccine-are-recommended-to-receive-further-doses-and. Accessed: 12 Nov 2024"},{"key":"4146_CR10","doi-asserted-by":"publisher","first-page":"ciae479","DOI":"10.1093\/cid\/ciae479","volume":"12","author":"M Horberg","year":"2003","unstructured":"Horberg M, Thompson M, Agwu A et al (2024) Primary Care Guidance for Providers of Care for Persons With Human Immunodeficiency Virus: 2024 Update by the HIV Medicine Association of the Infectious Diseases Society of America. Clin Infect Dis 12:ciae479. https:\/\/doi.org\/10.1093\/cid\/ciae479. Epub ahead of print. PMID: 39393187","journal-title":"Clin Infect Dis"},{"issue":"7","key":"4146_CR11","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.3109\/0886022X.2015.1055698","volume":"37","author":"F Yousaf","year":"2015","unstructured":"Yousaf F, Gandham S, Galler M et al (2015) Systematic review of the efficacy and safety of intradermal versus intramuscular hepatitis B vaccination in end-stage renal disease population unresponsive to primary vaccination series. Ren Fail 37(7):1080\u20131088","journal-title":"Ren Fail"},{"key":"4146_CR12","doi-asserted-by":"publisher","DOI":"10.4103\/sjg.SJG_300_20","author":"FM Hanif","year":"2020","unstructured":"Hanif FM, Mehmood N, Majid Z et al (2020) Successful response of intradermal hepatitis B vaccine in nonresponders of intramuscular hepatitis B vaccine in general and hemodialysis population. Saudi J Gastroenterol. https:\/\/doi.org\/10.4103\/sjg.SJG_300_20","journal-title":"Saudi J Gastroenterol"},{"issue":"Suppl 2","key":"4146_CR13","first-page":"S33","volume":"89","author":"T Chanchairujira","year":"2006","unstructured":"Chanchairujira T, Chantaphakul N, Thanwandee T et al (2006) Efficacy of intradermal hepatitis B vaccination compared to intramuscular vaccination in Hemodialysis patients. J Med Assoc Thai 89(Suppl 2):S33\u2013S40","journal-title":"J Med Assoc Thai"},{"issue":"2","key":"4146_CR14","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1002\/hep.510310237","volume":"31","author":"F Rahman","year":"2000","unstructured":"Rahman F, Dahmen A, Herzog-Hauff S et al (2000) Cellular and humoral immune responses induced by intradermal or intramuscular vaccination with the major hepatitis B surface antigen. Hepatology 31(2):521\u2013527. https:\/\/doi.org\/10.1002\/hep.510310237","journal-title":"Hepatology"},{"issue":"9","key":"4146_CR15","doi-asserted-by":"publisher","DOI":"10.3390\/v15091844","volume":"15","author":"E Tortellini","year":"2023","unstructured":"Tortellini E, Fosso Ngangue YC, Dominelli F et al (2023) Immunogenicity and efficacy of vaccination in people living with human immunodeficiency virus. Viruses 15(9):1844. https:\/\/doi.org\/10.3390\/v15091844","journal-title":"Viruses"},{"issue":"5","key":"4146_CR16","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines11050921","volume":"11","author":"L Nie","year":"2023","unstructured":"Nie L, Hua W, Liu X et al (2023) Associated factors and immune response to the hepatitis B vaccine with a standard schedule: a prospective study of people with HIV in China. Vaccines 11(5):921. https:\/\/doi.org\/10.3390\/vaccines11050921","journal-title":"Vaccines"},{"issue":"11","key":"4146_CR17","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0080409","volume":"8","author":"K Chaiklang","year":"2013","unstructured":"Chaiklang K, Wipasa J, Chaiwarith R et al (2013) Comparison of immunogenicity and safety of four doses and four double doses vs. standard doses of hepatitis B vaccination in HIV-infected adults: a randomized, controlled trial. PLoS ONE 8(11):e80409. https:\/\/doi.org\/10.1371\/journal.pone.0080409","journal-title":"PLoS ONE"},{"issue":"27","key":"4146_CR18","doi-asserted-by":"publisher","first-page":"3582","DOI":"10.1016\/j.vaccine.2021.05.044","volume":"39","author":"Y Feng","year":"2021","unstructured":"Feng Y, Yao T, Chang Y et al (2021) Immunogenicity and persistence of high-dose recombinant hepatitis B vaccine in adults infected with human immunodeficiency virus in China: a randomized, double-blind, parallel controlled trial. Vaccine 39(27):3582\u20133589. https:\/\/doi.org\/10.1016\/j.vaccine.2021.05.044","journal-title":"Vaccine"},{"issue":"24","key":"4146_CR19","doi-asserted-by":"publisher","first-page":"3995","DOI":"10.1016\/j.vaccine.2020.04.022","volume":"38","author":"JH Lee","year":"2020","unstructured":"Lee JH, Hong S, Im JH et al (2020) Systematic review and meta-analysis of immune response of double dose of hepatitis B vaccination in HIV-infected patients. Vaccine 38(24):3995\u20134000. https:\/\/doi.org\/10.1016\/j.vaccine.2020.04.022","journal-title":"Vaccine"},{"issue":"11","key":"4146_CR20","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1016\/S1473-3099(15)00220-0","volume":"15","author":"D Rey","year":"2015","unstructured":"Rey D, Piroth L, Wendling MJ et al (2015) Safety and immunogenicity of double-dose versus standard-dose hepatitis B revaccination in non-responding adults with HIV-1 (ANRS HB04 B-BOOST): a multicentre, open-label, randomised controlled trial. Lancet Infect Dis 15(11):1283\u20131291. https:\/\/doi.org\/10.1016\/S1473-3099(15)00220-0","journal-title":"Lancet Infect Dis"},{"issue":"8","key":"4146_CR21","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.20929","volume":"4","author":"JI Vargas","year":"2021","unstructured":"Vargas JI, Jensen D, Mart\u00ednez F et al (2021) Comparative efficacy of a high-dose vs standard-dose hepatitis B revaccination schedule among patients with HIV: a randomized clinical trial. JAMA Netw Open 4(8):e2120929. https:\/\/doi.org\/10.1001\/jamanetworkopen.2021.20929","journal-title":"JAMA Netw Open"},{"issue":"14","key":"4146_CR22","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1001\/jama.2011.351","volume":"305","author":"O Launay","year":"2011","unstructured":"Launay O, van der Vliet D, Rosenberg AR et al (2011) Safety and immunogenicity of 4 intramuscular double doses and 4 intradermal low doses vs standard hepatitis B vaccine regimen in adults with HIV-1: a randomized controlled trial. JAMA 305(14):1432\u20131440. https:\/\/doi.org\/10.1001\/jama.2011.351","journal-title":"JAMA"},{"issue":"5","key":"4146_CR23","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1001\/jamainternmed.2016.0741","volume":"176","author":"O Launay","year":"2016","unstructured":"Launay O, Rosenberg AR, Rey D et al (2016) Long-term immune response to hepatitis B virus vaccination regimens in adults with human immunodeficiency virus 1: secondary analysis of a randomized clinical trial. JAMA Intern Med 176(5):603\u2013610. https:\/\/doi.org\/10.1001\/jamainternmed.2016.0741","journal-title":"JAMA Intern Med"},{"issue":"5","key":"4146_CR24","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1111\/j.1468-1293.2007.00473.x","volume":"8","author":"SD Shafran","year":"2007","unstructured":"Shafran SD, Mashinter LD, Lindemulder A et al (2007) Poor efficacy of intradermal administration of recombinant hepatitis B virus immunization in HIV-infected individuals who fail to respond to intramuscular administration of hepatitis B virus vaccine. HIV Med 8(5):295\u2013299. https:\/\/doi.org\/10.1111\/j.1468-1293.2007.00473.x","journal-title":"HIV Med"},{"issue":"5","key":"4146_CR25","doi-asserted-by":"publisher","first-page":"519","DOI":"10.7883\/yoken.JJID.2021.834","volume":"75","author":"Y Yoshimura","year":"2022","unstructured":"Yoshimura Y, Sasaki H, Miyata N et al (2022) Intradermal hepatitis B vaccination in non-responder people living with human immunodeficiency virus in Japan. Jpn J Infect Dis 75(5):519\u2013522. https:\/\/doi.org\/10.7883\/yoken.JJID.2021.834","journal-title":"Jpn J Infect Dis"},{"issue":"4","key":"4146_CR26","doi-asserted-by":"publisher","first-page":"e003597","DOI":"10.1136\/rmdopen-2023-003597","volume":"9","author":"VC Rom\u00e3o","year":"2003","unstructured":"Rom\u00e3o VC, \u00c1vila-Ribeiro P, Gon\u00e7alves MJ et al (2024) Hepatitis B vaccination associated with low response in patients with rheumatic diseases treated with biologics [published correction appears in RMD Open. ;10(1):]. RMD Open. 9(4):e003597 https:\/\/doi.org\/10.1136\/rmdopen-2023-003597","journal-title":"RMD Open"},{"issue":"5","key":"4146_CR27","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1080\/21645515.2019.1574151","volume":"15","author":"A Haykir Solay","year":"2019","unstructured":"Haykir Solay A, Eser F (2019) High dose hepatitis B vaccine is not effective in patients using immunomodulatory drugs: a pilot study. Hum Vaccin Immunother 15(5):1177\u20131182. https:\/\/doi.org\/10.1080\/21645515.2019.1574151","journal-title":"Hum Vaccin Immunother"},{"issue":"2","key":"4146_CR28","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1086\/502012","volume":"23","author":"EG Playford","year":"2002","unstructured":"Playford EG, Hogan PG, Bansal AS et al (2002) Intradermal recombinant hepatitis B vaccine for healthcare workers who fail to respond to intramuscular vaccine. Infect Control Hosp Epidemiol 23(2):87\u201390. https:\/\/doi.org\/10.1086\/502012","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"12","key":"4146_CR29","doi-asserted-by":"publisher","first-page":"1782","DOI":"10.1111\/jgh.13022","volume":"30","author":"O Kalchiem-Dekel","year":"2015","unstructured":"Kalchiem-Dekel O, Grupel D, Bouchnik L et al (2015) Efficacy and long-term durability of intradermal recombinant hepatitis B virus vaccine among intramuscular vaccine nonresponders: a prospective study in healthcare personnel. J Gastroenterol Hepatol 30(12):1782\u20131787. https:\/\/doi.org\/10.1111\/jgh.13022","journal-title":"J Gastroenterol Hepatol"},{"issue":"5","key":"4146_CR30","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1016\/j.vaccine.2017.12.038","volume":"36","author":"S Jackson","year":"2018","unstructured":"Jackson S, Lentino J, Kopp J (2018) Immunogenicity of a two-dose investigational hepatitis B vaccine, HBsAg-1018, using a toll-like receptor 9 agonist adjuvant compared with a licensed hepatitis B vaccine in adults. Vaccine 36(5):668\u2013674. https:\/\/doi.org\/10.1016\/j.vaccine.2017.12.038","journal-title":"Vaccine"},{"issue":"3","key":"4146_CR31","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1093\/cid\/ciad201","volume":"77","author":"KM Marks","year":"2023","unstructured":"Marks KM, Kang M, Umbleja T et al (2023) Immunogenicity and safety of hepatitis B virus (HBV) vaccine with a toll-like receptor 9 agonist adjuvant in HBV vaccine-na\u00efve people with human immunodeficiency virus. Clin Infect Dis 77(3):414\u2013418. https:\/\/doi.org\/10.1093\/cid\/ciad201","journal-title":"Clin Infect Dis"},{"issue":"4","key":"4146_CR32","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1001\/jama.2024.24490","volume":"333","author":"KM Marks","year":"2025","unstructured":"Marks KM, Kang M, Umbleja T et al (2025) HepB-CpG vs HepB-Alum vaccine in people with HIV and prior vaccine nonresponse: the bee-HIVe randomized clinical trial. JAMA 333(4):295\u2013306. https:\/\/doi.org\/10.1001\/jama.2024.24490","journal-title":"JAMA"}],"container-title":["Irish Journal of Medical Science (1971 -)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11845-025-04146-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11845-025-04146-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11845-025-04146-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T09:14:43Z","timestamp":1772874883000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11845-025-04146-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,3]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["4146"],"URL":"https:\/\/doi.org\/10.1007\/s11845-025-04146-5","relation":{},"ISSN":["0021-1265","1863-4362"],"issn-type":[{"value":"0021-1265","type":"print"},{"value":"1863-4362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,3]]},"assertion":[{"value":"23 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics declarations"}},{"value":"This study was conducted with the approval of Istanbul University-Cerrahpasa, Cerrahpasa Medical Faculty Clinical Research Ethics Committee (Date: 04.08.2021, no: E-52825153-604.01.01-125038). The requirement for individual informed consent was waived by the committees because of the retrospective nature of the study. All procces in this research was carried out in accordance with the ethical standards of the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declared no potential conflicts of interest with respect to the research, authorship, and\/or publication of this article.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicting Interests"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial number"}}]}}